Etomoxir appears `to have promise as a novel form of therapy for heart failure'

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1264, 2000-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuregulin1 as Novel Therapy for Heart Failure

By  

Current Pharmaceutical Design, Vol. 17, Iss. 18, 2011-06 ,pp. : 1808-1817

Bentham Science Publishers

Access to resources Recommend Favorite

LVAD + pharmacotherapy appears to reverse heart failure

By  

Inpharma, Vol. 1, Iss. 1563, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?

By Demers Catherine   McKelvie Robert S  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1009-1018

Informa Healthcare

Access to resources Recommend Favorite

Metabolic Therapy of Heart Failure

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2582-2591

Bentham Science Publishers

Access to resources Recommend Favorite

Heart failure investigation appears to be appropriate, but improved organisation of care

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 391, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite